Hope is on the horizon for patients living with chronic obstructive pulmonary disease (COPD). CHEST 2024 in Boston featured a session highlighting emerging bronchoscopic therapies.

CMS actuaries foresee a gradual rise in per capita health spending, slowing initially but eventually outpacing economic ...

A systematic review analyzing sleep quality and the impact of zinc supplements reveals glaring gaps in knowledge in this area ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The suggestive evidence should encourage research into the associations to evaluate the association with stronger evidence.

The Heart Failure Society of America (HFSA) annual meeting 2024 was scheduled to showcase groundbreaking research on the ...

New data presented at CHEST 2024 in Boston revealed a significant link between obstructive sleep apnea and mental health disorders in middle-aged and older adults.

At the CHEST 2024 annual meeting, international respiratory society leaders highlighted the need for global collaboration to ...

Recent results from a new diabetes reversal program demonstrate the reliable, sustained benefits of nonpharmacological interventions in the management of diabetes and overall health of patients.

Between 2011 and 2020, the Veterans Health Administration spent $78 billion on health services for veterans also enrolled in ...